Model
Edge
Alnylam Pharmaceuticals, Inc.
0001829252
Filing Type
144
Filing Date
10/2/2025
Updated
10/3/25, 2:08 PM
Filing
144
Earnings Release
Exhibits
144
Notice of Proposed Sale of Securities